<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
January 24, 2000
NURESCELL INC.
(Exact name of registrant as specified in its charter)
Nevada 0-25377 33-0805583
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification
Number)
1400 Bristol Street N., Suite 240, Newport Beach, California 92660
(Address of principal executive offices)
(949) 752-0071
(Registrant's telephone number)
<PAGE>
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
On January 24, 2000, the Company re-engaged Hollander, Lumer & Co. LLP
as its independent auditors and independent certified public accountant. Such
re-engagement occurred when Deloitte & Touche LLP ("Deloitte") declined to
accept an engagement in that capacity. Deloitte had not reviewed, audited or
rendered any opinion on any financial statements of the Company as of any
date or for any period.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Dated: January 28, 2000 NURESCELL INC.
By: /s/ Sharon Nitka
-------------------------------------
Sharon Nitka, Chief Financial Officer
